Novel D-form of hybrid peptide (D-AP19) rapidly kills Acinetobacter baumannii while tolerating proteolytic enzymes

Antimicrobial peptides (AMPs) are being developed as potent alternative treatments to conventional antibiotics which are unlikely to induce bacterial resistance. They can be designed and modified to possess several druggable properties. We report herein a novel hybrid peptide of modified aurein (A3)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jariyarattanarach, Phanvimon, Klubthawee, Natthaporn, Wongchai, Mathira, Roytrakul, Sittiruk, Aunpad, Ratchaneewan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508196/
https://www.ncbi.nlm.nih.gov/pubmed/36151303
http://dx.doi.org/10.1038/s41598-022-20236-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508196/
https://www.ncbi.nlm.nih.gov/pubmed/36151303
http://dx.doi.org/10.1038/s41598-022-20236-1

Ejemplares similares